Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target is $463.00. Whit Mayo has given his Buy rating due ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $478.00. The company’s shares closed ...

Elevance Health shares fell 21% in 2024 due to weak fundamental performance, with revenue growing low-single-digits and flat earnings per share. The company is expanding its non-insurance ...

Analysts' ratings for Elevance Health ELV over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates the ...

INDIANAPOLIS — INDIANAPOLIS — Elevance Health Inc. (ELV) on Thursday reported fourth-quarter net income of $418 million. The Indianapolis-based company said it had net income of $1.81 per share.

Whales with a lot of money to spend have taken a noticeably bullish stance on Elevance Health. Looking at options history for Elevance Health ELV we detected 10 trades. If we consider the ...

Analysts use this formula to calculate it for Elevance Health: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.13 = US$10b ÷ (US$ ...

Unless the payments are sustainable, the dividend yield doesn't mean too much. Before making this announcement, Elevance Health was easily earning enough to cover the dividend. As a result, a large ...

View Our Latest Analysis on ELV Elevance Health Price Performance Elevance Health stock opened at $388.93 on Thursday. Elevance Health, Inc. has a 12 month low of $362.21 and a 12 month high of ...